As part of the activities of the Country Coordinating Mechanism (CCM) for the Global Fund to Fight AIDS, Tuberculosis and Malaria in Vietnam, an oversight visit mission was conducted at the National Lung Hospital, the Principal Recipient for the Global Fund project for TB control in the period 2024 – 2026. The mission aimed to assess progress toward technical targets, review disbursement performance, and examine the implementation of the Global Fund’s budget-reduction recommendations to ensure transparency and effective use of international support.
The project is carried out nationally in partnership with TB control units across 63 provinces and cities, agencies under the Ministry of Health, Ministry of Public Security, Ministry of Labor, Invalids and Social Affairs, as well as numerous social organizations and private healthcare facilities. With a total non-refundable grant of USD 63.8 million, the project contributes to Viet Nam’s strategic TB control goals for 2021 – 2026: reducing TB incidence by 50% and TB mortality by 75% by 2026 compared to 2018, maintaining drug-resistant TB prevalence below 5%, and halving the proportion of households experiencing catastrophic costs due to TB.

According to the National Lung Hospital, the first half of 2025 recorded strong technical performance. The project detected 50,070 new and relapsed TB cases (exceeding the annual target), rapid diagnostic testing for 29,318 patients (133% of the target), and treatment for 1,418 drug-resistant TB cases (70.8%). Latent TB infection treatment also reached 84.9% of the target, with 33,963 contacts treated. However, case-management indicators among private-sector providers and incarcerated populations remain below expectations, underscoring the need for strengthened intersectoral coordination.
In terms of financial performance, as of July 2025, the project had disbursed USD 15.33 million, equivalent to 56.4% of the approved budget. The largest expenditures were allocated to diagnosis, treatment, and patient-care modules. However, budget cuts mandated by the Global Fund have impacted training, oversight, and research activities, jeopardizing the treatment success rates and service quality. Additionally, implementation timescales are also under strain due to modifications in financial and human resource management regulations.

The oversight visit reaffirmed CCM’s critical role in promoting transparency, accountability, and effective utilization of donor resources. Beyond compliance monitoring, the mission served as an opportunity for stakeholders to jointly identify solutions and make timely adjustments to maintain progress toward national TB control objectives. The delegation recommended prioritizing resources for direct patient support, integrating project activities into the national target program, advocating for expedited drug-import licensing, and supporting provincial authorities in mobilizing domestic financing to ensure long-term sustainability.
CCM’s oversight at the National Lung Hospital underscores the importance of an independent monitoring mechanism, enabling real-time course corrections and contributes to Viet Nam’s vision of ending the TB burden by 2030.
CCM Secretariat


Your comments will be reviewed before being posted. Please write a signed comment.